EP2167066
DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF ATTENTION DEFICIT DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.5.2008EP published:
26.6.2013EP application number:
08769311.5
EPO information:
European Patent Register
Max expiry date:
6.5.2028
Title:
DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF ATTENTION DEFICIT DISORDERS
Timeline
Today
7.5.2008EP application
26.6.2013EP Publication
Owner
Name:
Chelsea Therapeutics, Inc.Address:
3530 Toringdon Way Suite 200, 28277, Charlotte, NC, US
Inventor
Name:
ROBERTS, Michael, J.Address:
Charlotte, NC, US
Name:
PEDDER, SimonAddress:
Fort Mill, SC, US
Priority
Number:
916497 PDate:
7.5.2007Country:
US
Classification
Categories:
A61K 31/198, A61K 31/195, A61K 31/275, A61K 31/138, A61K 31/345, A61K 45/06